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Abstract
Immunoglobulin E (IgE) activates mast cells (MCs). It remains
unknown whether IgE also activates other inflammatory cells, and
contributes to the pathogenesis of abdominal aortic aneurysms
(AAAs). This study demonstrates that CD4
+ T cells express IgE
receptor FceR1, at much higher levels than do CD8
+ T cells. IgE
induces CD4
+ T-cell production of IL6 and IFN-c, but reduces their
production of IL10. FceR1 deficiency (Fcer1a
/) protects apolipo-
protein E-deficient (Apoe
/) mice from angiotensin-II infusion-
induced AAAs and reduces plasma IL6 levels. Adoptive transfer of
CD4
+ T cells (but not CD8
+ T cells), MCs, and macrophages from
Apoe
/ mice, but not those from Apoe
/ Fcer1a
/ mice,
increases AAA size and plasma IL6 in Apoe
/ Fcer1a
/ recipient
mice. Biweekly intravenous administration of an anti-IgE monoclo-
nal antibody ablated plasma IgE and reduced AAAs in Apoe
/
mice. Patients with AAAs had significantly higher plasma IgE levels
than those without AAAs. This study establishes an important role
of IgE in AAA pathogenesis by activating CD4
+ T cells, MCs, and
macrophages and supports consideration of neutralizing plasma
IgE in the therapeutics of human AAAs.
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Introduction
Mast cells (MCs) contribute importantly to the pathogenesis of
atherosclerosis and abdominal aortic aneurysms (AAAs) (Kovanen,
2007; Sun et al, 2007a,b; Bot & Biessen, 2011; Swedenborg et al,
2011). After activation, MCs release pro-inflammatory cytokines
(e.g. IFN-c and IL6) to induce matrix-degrading protease expression
from vascular smooth muscle cells (SMCs) and endothelial cells
(ECs) (Sun et al, 2007a,b); MC-specific proteases (e.g. chymase and
tryptase) to induce vascular cell apoptosis (Heikkila ¨ et al, 2008; Sun
et al, 2009; Zhang et al, 2011; den Dekker et al, 2012); angiogenic
factors (e.g. basic fibroblast growth factor) to stimulate angiogenesis
(Lappalainen et al, 2004); and histamine to induce EC inflammatory
responses (Dileepan & Stechschulte, 2006). Multiple mechanisms—
including lipoproteins, immunoglobulins, neurotrophic factors (e.g.
substance P and neuron growth factor), stem cell factor, complements
(e.g. C3a and C5a), endotoxin, inflammatory cytokines (e.g. IL1 and
TNF-a) (Xu & Shi, 2012), or even acute restraint stress (Huang et al,
2002)—can mediate MC activation. Among these MC activators,
immunoglobulin E (IgE) is probably the best known (Ishizaka et al,
1978; Razin et al, 1983; Dvorak et al, 1985). Mast cells inactivation
by blocking IgE activity by use of anti-IgE antibodies has been inves-
tigated widely among patients with allergic asthma, food allergy,
atopic dermatitis, atopic eczema, chronic autoimmune urticaria, and
chronic rhinosinusitis (Milgrom et al, 1999; Leung et al, 2003; Busse
et al, 2011). We recently found that in addition to MCs, IgE also
targets macrophages, SMCs, and ECs, and induces cytokine and
chemokine production from these atherosclerosis-pertinent cells
(Wang et al, 2011). This study demonstrates that T cells express IgE
high affinity receptor FceR1. Using angiotensin-II (Ang-II) infusion-
induced experimental AAAs in apolipoprotein E-deficient (Apoe
/)
mice, we tested whether IgE actions on T cells, MCs, and macrophag-
es contribute to AAA pathogenesis and whether inhibition of IgE
activity using FceR1-deficient mice or ablation of plasma IgE using
anti-IgE monoclonal antibody (mAb) ameliorates AAA development.
Results
FceR1 expression on CD4
+ and CD8
+ T cells
Inflammatory cells express the high-affinity IgE receptor FceR1, e.g.
MCs, basophils, eosinophils, dendritic cells, Langerhans cells,
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1996; Boesiger et al, 1998; Dombrowicz et al, 2000; Katoh et al,
2000; Grayson et al, 2007; Mancardi et al, 2008). Neurons and
vascular SMCs and ECs also express FceR1 (Andoh & Kuraishi,
2004; Wang et al, 2011), suggesting a broad spectrum of target cells
for IgE. IgE activates MCs by targeting FceR1 (Xu & Shi, 2012). We
have recently shown that IgE also activates macrophages via inter-
action with cell surface FceR1 (Wang et al, 2011). This study used
CD4
+ and CD8
+ T cells selected from splenocytes from wild-type
C57BL/6 mice by nylon wool column purification and consequently
anti-I-A
b antibody depletion (Kokkinopoulos et al, 1992), followed
by anti-CD4 and anti-CD8 antibody-coated magnetic column positive
selection. Cell purity ranged from 94 to 98% (Supplementary Fig
S1). To examine whether T cells also express FceR1, we treated both
CD4
+ and CD8
+ T cells with IgE, inflammatory cytokines (IFN-c,
IL6, and TNF-a), or Ang-II. Real-time polymerase chain reaction
(RT-PCR) demonstrated the expression of mRNAs that encode all
three FceR1 subunits—FceR1a,F c eR1b, and FceR1c—in CD4
+ T
cells, but at much lower levels in CD8
+ T cells. Cell stimulation
with IgE, cytokines, or Ang-II did not significantly change FceR1
expression from either CD4
+ or CD8
+ T cells (Fig 1A). To deter-
mine what percentages of these T cells express FceR1, we gated total
CD3
+ T cells from mouse splenocytes and selected CD4
+ and CD8
+
T cells to detect the percentage of FceR1
+ cells in these two popula-
tions of T cells (Supplementary Fig S2). Flow cytometry (FACS)
analysis of splenocytes using anti-FceR1a-biotin mAb demonstrated
comparable percentages of CD4
+ and CD8
+ T cells that express
surface FceR1a, but negligible intracellular FceR1a after subtracting
the baseline signals from the antibody isotype controls (Fig 1B).
Supplementary Fig S3 shows a representative FACS analysis. To
compare the relative expression of the same three FceR1 subunits in
CD4
+ T cells to those of cells known to express FceR1, we
performed RT-PCR from both bone marrow-derived MC (BMMCs)
and macrophages and found that BMMCs and macrophages
expressed much higher levels of the FceR1a subunit, but compara-
ble levels of FceR1b (BMMCs: 0.08–0.17%; macrophages: <0.001–
0.025% relative to b-actin) and FceR1c (BMMCs: 0.40–0.80%;
macrophages: 0.09–1.27% relative to b-actin) subunits to those of
CD4
+ T cells, depending on the stimulus (Fig 1C). Immunoblot
analysis showed that FceR1 protein expression was also much
higher in CD4
+ T cells than in CD8
+ T cells and that IgE, cytokines,
and Ang-II did not affect FceR1a expression (Fig 1D), concordant
the results of RT-PCR and FACS analysis (Fig 1A and B). These data
suggest that CD4
+ T cells expressed much higher levels of FceR1
(RT-PCR) than did CD8
+ T cells, although similar percentages of
these T cells expressed FceR1 (FACS). We have previously shown
that either aggregated (SPE-7) or monomeric (H1 DNP-e-206) forms
of IgE have equal potency as macrophage activators, and that IgE
antigen did not affect this activity of IgE (Wang et al, 2011). To test
whether FceR1 on CD4
+ and CD8
+ T cells was functional and also
independent of antibody cross-linking, we demonstrated that SPE-7
IgE produced a concentration-dependent increase in the expression
of IL6 and IFN-c mRNA and protein production by CD4
+ and CD8
+
T cells, as determined by RT-PCR (Fig 1E) and by culture medium
ELISA (Fig 1F). In contrast, CD4
+ T cells showed biphasic but insig-
nificant changes in IL10 mRNA levels after exposure to low concen-
trations of IgE (0–10 lg/ml), but demonstrated significant reduction
of IL10 expression under high IgE concentrations (50–100 lg/ml)
(Fig 1E). Cell culture medium ELISA showed that IgE activation
dose-dependently reduced CD4
+ T-cell IL10 production (Fig 1F).
Consistent with the differences in FceR1 expression levels between
CD4
+ and CD8
+ T cells, cellular IFN-c mRNA levels and medium IL6
protein levels were significantly higher in CD4
+ T cells than in CD8
+
T cells at various IgE concentrations. In contrast, we detected minimal
levels of mRNA and medium IL10 in CD8
+ T cells (Fig 1E and F).
Why IgE promotes MC and basophil survival and proliferation
(Kawakami & Galli, 2002), but induces macrophage apoptosis (Wang
et al, 2011), remains unknown. Altered cytokine expression from
IgE-treated CD4
+ and CD8
+ T cells may result from IgE actions affect-
ing T-cell survival or proliferation. To test this possibility, we cultured
both CD4
+ and CD8
+ T cells in anti-CD3 (1 lg/ml) and anti-CD28
(1 lg/ml) monoclonal antibodies and stimulated these cells with IgE
(50 lg/ml) for 3 days. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) cell survival assay and medium IL2 ELISA
demonstrated that IgE did not affect either survival or proliferation of
CD4
+ or CD8
+ T cells from either Apoe
/ mice or FceR1a-deficient
Apoe
/ Fcer1a
/ mice (Supplementary Fig S4A–D).
Absence of FceR1 reduces experimental AAAs in Apoe
/ mice
Chronic subcutaneous infusion of Ang-II induces experimental
AAAs in Apoe
/ mice (Daugherty et al, 2000; Schulte et al, 2010;
Zhang et al, 2012). We first tested whether AAA development in
Apoe
/ mice associates with plasma IgE level changes. Among 16
Apoe
/ mice that received Ang-II infusion, 13 developed AAAs and
3 did not. Mice with confirmed AAAs had significantly higher
plasma IgE levels than those before Ang-II infusion or those that did
not develop AAA even after receiving Ang-II (Fig 2A), although
their blood pressures or heart rates did not differ significantly
(Supplementary Fig S5). Increased plasma IgE may trigger inflam-
matory cytokine expression from T cells, MCs, macrophages, and
other inflammatory cells, thereby promoting AAA pathogenesis.
Interruption of IgE activity may thus attenuate AAA growth. To test
this hypothesis, we produced Ang-II infusion-induced AAAs in both
FceR1-sufficient Apoe
/ mice and FceR1-deficient Apoe
/Fcer1a
/
mice. In these experiments, Apoe
/ mice tended to hvae a higher
post-Ang-II infusion mortality rate than that of Apoe
/Fcer1a
/
mice (40% versus 20%, P = 0.314, Fig 2B). To achieve sufficient
numbers of mice that survived from Ang-II infusion and for AAA
lesion analysis, we used 30 Apoe
/ mice and 15 Apoe
/Fcer1a
/
mice to provide 18 Apoe
/ and 12 Apoe
/Fcer1a
/ survivors
after 28 days of Ang-II infusion. Apoe
/Fcer1a
/ mice showed a
much lower AAA incidence than did Apoe
/ mice (33.3% versus
83.3%, P = 0.008, Fig 2B). Suprarenal maximal outer aortic diame-
ters measured in situ from anesthetized mice were significantly
smaller in Apoe
/Fcer1a
/ mice than in Apoe
/ mice (Fig 2B).
As we anticipated, Apoe
/ and Apoe
/Fcer1a
/ mice that devel-
oped AAAs had significantly higher plasma IgE levels than did those
did not develop AAAs, although FceR1-deficiency enhanced plasma
IgE levels post-Ang-II infusion, independent of AAA formation. In
contrast, plasma IgG or IgM levels did not change significantly in
mice with and without AAAs from either genotype (Fig 2C). AAA
lesion inflammation (macrophage-positive area, T-cell content,
dendritic cell content, major histocompatibility complex [MHC]
class-II content, and chemokine monocyte chemoattractant protein-
1 [MCP-1] content), lesion cell proliferation (Ki67-positive areas),
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954microvessel number (CD31), apoptotic cell number, media elastin
fragmentation, and presence of SMC in the tunica media (loss of
media SMCs) were all significantly lower in AAA lesions from
Apoe
/Fcer1a
/ mice than in lesions from Apoe
/ mice (Fig 2D
and E). However, FceR1 deficiency did not significantly affect body
weight, diastolic and systolic blood pressures, heart rate, plasma
lipid profiles (Supplementary Fig S6A–E) before or after AAA
production, or AAA lesion total interstitial collagen contents
(Supplementary Fig S6F). These observations establish an important
role of IgE in AAA pathogenesis.
IgE actions on CD4
+ T cells are essential to AAAs
Increased plasma IgE in AAA mice (Fig 2A and C), reduced AAAs in
FceR1-deficient Apoe
/Fcer1a
/ mice (Fig 2B), and increased IL6
and IFN-c and reduced IL10 in CD4
+ T cells after IgE activation
(Fig 1E and F) suggest a role of IgE actions on CD4
+ T cells in AAAs.
To test this hypothesis, we adoptively transferred equal numbers
(1 × 10
7 per recipient) of splenic CD4
+ T cells from age-matched
Apoe
/ mice and Apoe
/Fcer1a
/ mice to Apoe
/Fcer1a
/ reci-
pient mice, followed by Ang-II infusion to elicit AAA formation. After
28 days, we confirmed the presence of FceR1a-positive donor cells in
AAA lesions of recipient Apoe
/Fcer1a
/ mice receiving CD4
+ T
cells from Apoe
/ mice (Fig 3A, left two panels) using a hamster
anti-mouse FceR1a antibody. Donor cells from Apoe
/Fcer1a
/
mice were used as negative controls for immunostaining (Fig 3A,
right panel). Antibody specificity was further tested using AAA lesion
consecutive sections with or without the primary antibody and using
AAA sections from the Apoe
/Fcer1a
/ mice (Supplementary Fig
S7). Low magnifications (20× or 40×) showing the entire aortas of
Apoe
/Fcer1a
/ recipient mice receiving donor cells from Apoe
/
mice and Apoe
/Fcer1a
/ mice are illustrated in Supplementary Fig
S8A. Immunofluorescent co-staining of AAA lesions from Apoe
/
Fcer1a
/ recipient mice receiving donor CD4
+ T cells from Apoe
/
mice for FceR1a and Ki67 demonstrated that donor CD4
+ T cells not
only targeted to the AAA lesions, but also underwent clonal expan-
sion (Fig 3B). As in Cd3e
/ mice (Milner et al, 2007), CD4
+ T-cell
reconstitution increased plasma IgE levels in recipient mice, but we
did not detect any differences between the two donor cells from
Apoe
/ mice and Apoe
/Fcer1a
/ mice (Fig 3C). Therefore,
CD4
+ T-cell-induced plasma IgE level increase did not depend on
FceR1 expression, although the mechanism by which CD4
+ T cells
augment recipient mice IgE levels remains incompletely understood
(Milner et al, 2007). Although not statistically significant, CD4
+ T
cells from Apoe
/ mice partially or fully restored both the AAA inci-
dence rate and post-Ang-II mortality rate in Apoe
/Fcer1a
/ reci-
pient mice much greater than those from Apoe
/Fcer1a
/ mice,
even though they had similar levels of plasma IgE (Fig 3C). Suprare-
nal aortic diameters were also significantly reversed in Apoe
/
Fcer1a
/ mice after receiving CD4
+ T cells from Apoe
/ mice, but
not those from Apoe
/Fcer1a
/ mice (Fig 3C). Reconstitution of
CD4
+ T cells from Apoe
/Fcer1a
/ mice did not affect recipient
mice lesion macrophage contents (Fig 3D, left panel), but lesion total
CD4
+ T-cell numbers did not differ significantly from those receiving
CD4
+ T cells from Apoe
/ mice (Fig 3D, middle panel)—suggesting
that absence of FceR1 on donor CD4
+ T cells did not affect AAA
lesion T-cell infiltration, but reduced macrophage accumulation.
Therefore, the FceR1 on CD4
+ T cells may be permissive for macro-
phage infiltration into AAA lesions, similar to the prior conclusion
that M1 macrophage infiltration in white adipose tissues requires
prior CD8
+ T-cell activation (Nishimura et al, 2009). Reduced
macrophages in AAA lesions from recipient mice receiving CD4
+ T
cells from Apoe
/Fcer1a
/ mice yielded lower levels of MHC class-
II—marker of inflammation (Zhang et al, 2012)—in these AAA
lesions, compared with those receiving CD4
+ T cells from Apoe
/
mice, although such difference did not reach statistical significance
(Fig 3D, right panel).
In contrast, recipient Apoe
/Fcer1a
/ mice receiving CD8
+ T
cells from Apoe
/ mice or Apoe
/Fcer1a
/ mice did not change
AAA formation in Apoe
/Fcer1a
/ recipient mice. Anti-FceR1a
mAb immunostaining and immunofluorescent co-staining together
with an anti-Ki67 rabbit polyclonal antibody of AAA lesion sections
from Apoe
/Fcer1a
/ recipient mice receiving donor CD8
+ T cells
from Apoe
/ mice showed the presence of donor CD8
+ T cells in
AAA lesions (Supplementary Fig S8B and S9A, left two panels) and
these donor cells also underwent clonal expansion (Supplementary
Fig S9B). Sections from recipient mice receiving CD8
+ T cells from
Apoe
/Fcer1a
/ mice served as negative controls for the FceR1a
mAb (Supplementary Fig S8B and S9A, right panel). Unlike donor
CD4
+ T cells, donor CD8
+ T cells from either Apoe
/ mice
or Apoe
/Fcer1a
/ mice did not increase plasma IgE levels
significantly (Supplementary Fig S9C). Although we detected mild
increases in AAA incidence in all mice that received donor CD8
+
T cells from Apoe
/ mice or Apoe
/Fcer1a
/ mice, and there
were complete reverses of the post-Ang-II mortality rate in mice
that received CD8
+ T cells from Apoe
/ mice but not from
Apoe
/Fcer1a
/ mice, suprarenal aortic diameters from Apoe
/
Fcer1a
/ mice that received donor cells from Apoe
/ mice or
Apoe
/Fcer1a
/ mice were not different from those of the
parental Apoe
/Fcer1a
/ mice (Supplementary Fig S9C).
Consistent with unchanged aortic diameters, AAA lesion macro-
phage content did not differ between Apoe
/Fcer1a
/ mice and
Figure 1.F c eR1 expression and activity in cells treated with or without different stimuli.
A RT-PCR to determine mRNA levels of three FceR1 subunits, FceR1a,F c eR1b, and FceR1c relative to b-actin from CD4
+ and CD8
+ T cells.
B FACS analysis to determine the percentage of FceR1a-expressing T cells by staining surface and intracellular FceR1a on CD4
+ and CD8
+ T cells after subtracting the
background signals from the IgG isotypes.
C RT-PCR to determine mRNA levels of three FceR1 subunits relative to b-actin from bone marrow-derived mast cells (BMMCs) and macrophages.
D Immunoblot analysis of FceR1a on CD4
+ and CD8
+ T cells. Both CD4
+ and CD8
+ T-cell immunoblots were from the same SDS–PAGE.
E RT-PCR to determine cytokine (IL6, IFN-c, and IL10) mRNA level changes in CD4
+ and CD8
+ T cells, treated with or without different doses of IgE (SPE-7) as indicated.
P values refer to comparisons to untreated cells (IgE = 0 lg/ml).
F ELISA to determine culture medium cytokine (IL6, IFN-c, and IL10) levels in CD4
+ and CD8
+ T cells, treated with and without different doses of IgE as indicated. P
values in black refer to comparisons to untreated cells (IgE = 0 lg/ml). P values in red refer to comparisons between CD4
+ and CD8
+ T cells.
Data information: Data in panels A-E are mean  SEM from 3–5 independent experiments.
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955those receiving CD8
+ T-cell adoptive transfer (Supplementary Fig
S9D, left panel), although lesion T-cell content and MHC class-II-
positive areas increased in AAA lesions from recipient mice
receiving donor cells from Apoe
/ mice, but did not reach statisti-
cal significance from those receiving donor cells from Apoe
/
Fcer1a
/ mice (Supplementary Fig S9D, right two panels). Our
Figure 2. Role of FceR1 in Ang-II infusion-induced AAAs.
A ELISA determined plasma IgE levels in Apoe
/ mice before and 28 days after Ang-II infusion with and without AAA formation.
B Post-Ang-II infusion rupture-associated mortality rate calculated from survived mice versus total mice used (indicated), and AAA incidence and maximal suprarenal
outer aortic diameter from in situ calculated from all survived mice.
C Plasma IgE, IgG, and IgM levels in survived mice with and without AAAs.
D, E AAA lesion macrophage content, CD4
+ T-cell content, dendritic cell content, major histocompatibility complex (MHC) class-II-positive area, and chemokine MCP-1-
positive area (D), and AAA lesion Ki67-positive proliferating cell number, CD31-positive microvessel number, TUNEL-positive apoptotic cell area, arterial wall elastin
fragmentation grade, and media smooth muscle cell (SMC) accumulation grade (E) from both Apoe
/ and Fcer1a
/Apoe
/ mice harvested at 28 days after Ang-II
infusion.
Data information: Data are mean  SEM. Number of mice per group is indicated in each bar.
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956Figure 3. IgE actions on CD4
+ T cells in AAAs.
A Anti-FceR1a antibody-mediated immunostaining to detect donor CD4
+ T cells from Apoe
/ mice (left two panels) and Fcer1a
/Apoe
/ mice (right panel) in
recipient Fcer1a
/Apoe
/ mice. Scale: 200 lm; insert scale: 50 lm.
BF c eR1a and Ki67 antibody-mediated immunofluorescent co-staining to detect proliferating donor CD4
+ T cells from Apoe
/ mice in recipient Fcer1a
/Apoe
/
mice. Scale: 200 lm; insert scale: 60 lm.
C, D (C) Plasma IgE level, AAA incidence, post-Ang-II infusion aortic rupture-associated mortality rate, and suprarenal maximal outer aortic diameter; and (D) AAA lesion
macrophage content, CD4
+ T-cell content, and major histocompatibility complex (MHC) class-II-positive area from Apoe
/ mice, Fcer1a
/Apoe
/ mice, and
Fcer1a
/Apoe
/ recipient mice receiving donor CD4
+ T cells from Apoe
/ and Fcer1a
/Apoe
/ mice. Data are mean  SEM. Number of mice per group is
indicated in each bar.
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957observations from Apoe
/Fcer1a
/ mice reconstituted with CD4
+
and CD8
+ T cells suggest that IgE effects on CD4
+ T cells influenced
AAApathogenesistoamuchgreaterextentthandidCD8
+Tce ll s.
AAA formation requires IgE actions on MCs and macrophages
The foregoing experiments established an important role of IgE on
CD4
+ T cells, but both MCs and macrophages also express FceR1
(Fig 1C) (Boesiger et al, 1998; Wang et al, 2011). IgE activates MCs
and induces MC degranulation and release of granule-associated
inflammatory mediators (Ishizaka et al, 1978; Razin et al, 1983;
Dvorak et al, 1985). IgE also activates macrophages to release cyto-
kines and chemokines or to undergo apoptosis (Wang et al, 2011).
IgE actions on these inflammatory cells therefore may also contrib-
ute to AAA pathogenesis as do those from CD4
+ T cells.
To examine the role of IgE activity on MCs in AAAs, we prepared
BMMCs from both Apoe
/ and Apoe
/Fcer1a
/ mice and adop-
tively transferred them intravenously into Apoe
/Fcer1a
/ reci-
pient mice, followed by Ang-II infusion to elicit AAA formation.
Anti-FceR1a mAb immunostaining demonstrated the anticipated
accumulation of donor FceR1a-positive BMMCs from Apoe
/ mice
in Apoe
/Fcer1a
/ recipient mouse AAA lesions (Supplementary
Fig S8C and Fig 4A, left two panels). The same immunostaining of
AAA sections from recipient mice that received BMMCs from
Apoe
/Fcer1a
/ mice tested antibody specificity (Supplementary
Fig S8C and Fig 4A, right panel). Similar to results obtained with
CD4
+ T-cell-reconstituted Apoe
/Fcer1a
/ recipient mice, BMMC
reconstitution increased recipient mice plasma IgE levels, but did not
differ between the two donor cells (Fig 4B). BMMCs from Apoe
/
mice, but not those from Apoe
/Fcer1a
/ mice, increased AAA inci-
dence, post-Ang-II mortality rate, and maximal outer aortic diameter
in Apoe
/Fcer1a
/ recipient mice (Fig 4B). Statistically insignificant
differences in AAA incidences and post-Ang-II mortality might be due
to our relatively small sample sizes. AAA lesion apoptotic cell number
(Fig 4C) and microvessel number (Fig 4D) were also restored partially
in recipient mice receiving BMMCs from Apoe
/ mice, but not receiv-
ing those from Apoe
/Fcer1a
/ mice. Surprisingly, reconstitution of
MCs—whether from Apoe
/ mice or Apoe
/Fcer1a
/ mice—did
not significantly increase recipient mice AAA lesion macrophage
content, while lesion T cells, MHC class-II-positive areas, or lesion cell
proliferation all tended to recover after BMMCs adoptive transfers,
although these trends did not achieve statistical significance (Supple-
mentary Fig S10). These data suggest that IgE actions on MCs have
limited impact on macrophage and T-cell infiltration in AAA lesions.
Macrophages in AAA lesions come from blood-borne monocytes,
but a short lifespan after repopulation in recipient mice (Leuschner
et al, 2012) made it technically difficult to study donor monocytes
in AAA recipient mice. Instead, we used macrophages, which do
successfully repopulate in recipient mice to study macrophage acti-
vation in experimental AAA (Xiong et al, 2009). FACS analysis
confirmed that peritoneal macrophages prepared from donor mice
contained > 95% macrophages after an adhesion selection to deplete
other cells (Supplementary Fig S11). Donor macrophages in AAA
lesions from recipient Apoe
/Fcer1a
/ mice were localized by
immunostaining frozen AAA sections with anti-FceR1a mAb.
FceR1a-positive donor macrophages from Apoe
/ mice appeared in
recipient Apoe
/Fcer1a
/ mouse AAA lesions (Supplementary Fig
S8D and Fig 5A, left two panels). Lesions from recipient mice
receiving macrophages from Apoe
/Fcer1a
/ mice served as
negative controls for immunostaining (Supplementary Fig S8D and
Fig 5A, right panel). Adoptive transfer of macrophages from either
Apoe
/ or Apoe
/Fcer1a
/ mice did not significantly change
plasma IgE levels (Fig 5B), but IgE actions on macrophages contrib-
uted to AAA formation. Donor macrophages from Apoe
/ mice,
but not those from Apoe
/Fcer1a
/ mice, increased recipient AAA
incidence and post-Ang-II mortality rate. Donor macrophages from
Apoe
/ mice, but not those from Apoe
/Fcer1a
/ mice, also
reversed outer aortic diameters in recipient mice, although such change
did not reach statistical significance (Fig 5B). Reconstitution of macro-
phages from Apoe
/ mice, but not those from Apoe
/Fcer1a
/
mice, also increased lesion macrophage-positive area, T-cell
number, and MHC class-II-positive area (Fig 5C), establishing a role
of IgE actions on macrophages in AAA lesions.
Anti-IgE monoclonal antibody administration limits experimental
AAA formation
Observations from this study suggest that IgE actions on CD4
+ T
cells (Fig 3), MCs (Fig 4), and macrophages (Fig 5) contribute inde-
pendently to experimental AAAs to different extents. These observa-
tions agree with prior studies that CD4
+ T cells, MCs, and
macrophages or their activation contribute directly and indepen-
dently to AAA formation (Xiong et al, 2004, 2009; Sun et al, 2007b).
Interference with IgE signaling by genetically depleting the high-
affinity IgE receptor FceR1 (Fig 2), or IgE neutralization using anti-
IgE antibodies, therefore could suppress AAA growth. To test this
hypothesis, we administered an anti-IgE mAb intravenously 1 day
before initiating the AAA (Ang-II mini-pump implantation), and
once more at 2 weeks after AAA initiation using doses previously
established as effective in allergic mice and humans (Coyle et al,
1996; Haile et al, 1999; Milgrom et al, 1999; Leung et al, 2003;
Busse et al, 2011). Two doses of anti-IgE antibody did not change
body weight before or after AAA formation (Fig 6A), but signifi-
cantly reduced plasma IgE by more than 70% (Fig 6B). IgE ablation
with anti-IgE antibody reduced AAA incidence, post-Ang-II mortality
rate, and outer aortic diameters (Fig 6B), although the differences in
AAA incidence and poat-Ang-II mortality rate did not reach statisti-
cal significance (Fisher’s exact test).
Our leukocyte (CD4
+ T cells, MCs, or macrophages) reconstitu-
tion experiments showed that IgE actions on each of these cell types
contributed directly, but to different extents, to AAA formation. As
we anticipated, anti-IgE antibody treatment, which should block IgE
activities on all these target cells, as well as intrinsic vascular cells
(Wang et al, 2011), significantly suppressed AAA lesion macro-
phage content, CD4
+ T-cell number, MHC class-II-positive area,
lesion cell apoptosis, microvessel number, and lesion cell prolifera-
tion (Fig 6C–F). Non-selective targeting of IgE actions using anti-IgE
antibody therapy thus yielded similar effects in suppressing AAA
pathogenesis (Fig 6) to those of genetic depletion of IgE receptor
FceR1 (Fig 2).
IgE actions alter levels of inflammatory cytokines in plasma
One of the most important activities of IgE on inflammatory cells is
to induce their pro-inflammatory cytokine production, which may
accelerate AAA formation. Reduced AAAs after interruption of IgE
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958interactions with inflammatory cells using either FceR1-deficient
mice or cells, or anti-IgE antibodies, may associate with reduced
circulating cytokine levels. In AAA patients, plasma IL6 levels range
from 20–40 pg/ml and correlate positively and significantly with
indexed aortic diameters (r = 0.285, P = 0.002, linear regression)
(Rohde et al, 1999). IL6 deficiency or antibody depletion of plasma
IL6 protects mice from aortic elastase perfusion-induced AAAs in
mice (Thompson et al, 2006), suggesting an important role of IL6 in
Figure 4. IgE actions on bone marrow-derived mast cells (BMMCs) in AAAs.
A Anti-FceR1a antibody-mediated immunostaining to detect donor BMMCs from Apoe
/ mice (left two panels) and Fcer1a
/Apoe
/ mice (right panel) in recipient
Fcer1a
/Apoe
/ mice. Scale: 200 lm, insert scale: 50 lm.
B Plasma IgE level, AAA incidence, post-Ang-II infusion aortic rupture-associated mortality rate, and suprarenal maximal outer aortic diameter.
C, D (C) AAA lesion TUNEL-positive apoptotic cell percentage; and (D) AAA lesion CD31-positive microvessel number Apoe
/ mice, Fcer1a
/Apoe
/ mice, and Fcer1a
/
Apoe
/ recipient mice receiving donor CD4
+ T cells from Apoe
/ and Fcer1a
/Apoe
/ mice. Representative AAA lesions from adoptive transferred mice for panels
(C) and (D) are shown to the right. Scale: 200 lm.
Data information: (B-D) Data are mean  SEM. Number of mice per group is indicated in each bar.
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959AAAs. This study demonstrated that plasma IL6 levels in Apoe
/
mice resemble those in AAA patients, and fell significantly in
Apoe
/Fcer1a
/ mice (Fig 7A). The sensitivity of the ELISA used
for IFN-c did not permit detection and analysis of plasma levels of
this important pro-inflammatory cytokine also implicated in AAA
pathogenesis (King et al, 2009). Low levels of plasma IFN-c in these
mice agreed with the observations that T cells produced 10-fold less
IFN-c than IL6 after IgE stimulation (Fig 1F). Reconstitution of CD4
+
T cells and MCs, but not CD8
+ T cells and macrophages, from
Apoe
/ mice significantly restored plasma IL6 levels (Fig 7B–E).
Plasma IL6 levels in recipient mice receiving macrophages from
Apoe
/Fcer1a
/ mice were significantly lower than those from
recipient mice receiving macrophages from Apoe
/ mice (Fig 7E).
While Apoe
/ mice receiving IgG treatment showed comparable
plasma IL6 levels to those of untreated Apoe
/ mice, those receiv-
ing two doses of an anti-IgE antibody demonstrated significant
reduction in plasma IL6 levels, to the levels from Apoe
/Fcer1a
/
mice (Fig 7F). These observations indicate the prominence of IL6 as a
mediator released after IgE activation of inflammatory cells. In contrast,
although IgE suppressed IL10 production from isolated CD4
+ Tc e l l sin
vitro (Fig 1E and F), we did not detect significant differences in plasma
IL10 levels between Apoe
/ and Apoe
/Fcer1a
/ mice, or those
that received different types of CD4
+ T cells, CD8
+ T cells, MCs, or
macrophages (Supplementary Fig S12A–E). Nor did anti-IgE anti-
body affect plasma IL10 levels in mice with experimental AAAs
(Supplementary Fig S12F), although IgE neutralization may affect
other untested circulating anti-inflammatory cytokines.
Increased plasma IgE levels in patients with AAAs
The use of IgE receptor FceR1-deficient mice, adoptive transfer of
various inflammatory cell types, and anti-IgE antibody therapy
Figure 5. IgE actions on macrophages in AAAs.
A Anti-FceR1a antibody-mediated immunostaining to detect donor macrophages from Apoe
/ mice (left two panels) and Fcer1a
/Apoe
/ mice (right panel) in
recipient Fcer1a
/Apoe
/ mice. Scale: 200 lm, insert scale: 50 lm.
B, C (B) Plasma IgE level, AAA incidence, post-Ang-II infusion aortic rupture-associated mortality rate, and suprarenal maximal outer aortic diameter; and (C). AAA lesion
macrophage content, CD4
+ T-cell content, and major histocompatibility complex (MHC) class-II-positive area from Apoe
/ mice, Fcer1a
/Apoe
/ mice, and
Fcer1a
/Apoe
/ recipient mice receiving donor CD4
+ T cells from Apoe
/ and Fcer1a
/Apoe
/ mice. Data are mean  SEM. The number of mice per group is
indicated in each bar.
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960established that IgE aggravates experimental AAA formation by acti-
vating mononuclear leukocytes. Mice have increased plasma IgE
under conditions that produce AAAs (Fig 2A and C, left panel). We
have previously reported that AAA patients have significantly higher
plasma MC chymase and tryptase levels than controls (Sun et al,
2009; Zhang et al, 2011). We therefore measured plasma IgE levels
Figure 6. Anti-IgE antibody treatment of experimental AAAs.
A Body weight in Apoe
/ mice that received control IgG and anti-IgE mAb before and after AAA production.
B Plasma IgE level, AAA incidence, post-Ang-II infusion aortic rupture-associated mortality rate, and suprarenal maximal outer aortic diameter.
C–F (C) Lesion macrophage content, CD4
+ T-cell content, and major histocompatibility complex (MHC) class-II-positive area; (D) Lesion TUNEL-positive apoptotic cell
content; (E) CD31-positive microvessel number; and (F) Lesion Ki67-positive proliferating cell number from Apoe
/ mice receiving control IgG or anti-IgE mAb.
Data information: Data are mean  SEM. The number of mice per group is indicated in each bar. Representative figures for panels C to E are shown to the right. Scale:
50 lm.
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961from 487 male AAA patients and compared them by ELISA with
those from 200 sex-matched and age-matched individuals without
AAAs. Plasma IgE levels showed skewed distribution, therefore data
analysis used the non-parametric Mann–Whitney test. AAA patients
had significantly higher plasma IgE levels than controls
(81.79  61.65 ng/ml versus 7.10  1.70 ng/ml, mean  SD,
P < 0.001) (Supplementary Table S1), although we were unable to
ascertain whether there were any differences in the events of type I
allergies, such as allergic asthma, allergic conjunctivitis, allergic
rhinitis, anaphylaxis, angioedema, urticaria, eosinophilia, penicillin
allergy, cephalosporin allergy, and food allergy between the two
populations because most of these clinical symptoms were diag-
nosed in community general practices. Receiver–operator character-
istic (ROC) curve analyses demonstrated that IgE levels discriminate
between AAA patients and controls (AUC [area under the ROC
curve] = 0.588, P < 0.001), with optimal sensitivity of 0.60 and
specificity of 0.59 (Supplementary Fig S13). Among this population,
patients with peripheral arterial disease (PAD) also had significantly
higher plasma IgE levels than controls (250.79  229.88 ng/ml
versus 15.32  3.33 ng/ml, mean  SD, P < 0.001) (Supplemen-
tary Table S1).
Increased IgE and FceR1 expression in human AAA lesions
We have previously shown that IgE activates human macrophages,
SMCs, and ECs, and induces their apoptosis (Wang et al, 2011). The
present study suggested a role of IgE stimulation of CD4
+ T cells,
MCs, and macrophages in experimental AAA formation. Inflammatory
Figure 7. Plasma IL6 levels from different groups of mice as determined by ELISA.
A–F Plasma IL6 levels in Apoe
/ and Fcer1a
/Apoe
/ mice (A) and Fcer1a
/Apoe
/ mice that received adoptive transfer of CD4
+ T cells (B), CD8
+ T cells (C), bone
marrow-derived mast cells (BMMCs) (D), and macrophages (E) from Apoe
/ and Fcer1a
/Apoe
/ mice, and Apoe
/ mice that received biweekly intravenous
administration of anti-IgE mAb or corresponding IgG control (F). Data are mean  SEM. The number of mice per group is indicated in each bar.
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962cells in human AAA lesions might also express IgE receptor FceR1
and bind for IgE. Indeed, CD68-positive macrophages demonstrated
expression of FceR1 and IgE in consecutive frozen sections of
human AAAs. Consistent with our prior study (Wang et al, 2011),
IgE-positive and FceR1-positive macrophages in human AAA lesions
also underwent apoptosis as shown by TUNEL-positivity (Fig 8A).
IgE binding to macrophages also triggers cytokine expression from
these cells (Wang et al, 2011) as in CD4
+ T cells. Immunofluores-
cent staining colocalized the expression of both IgE and FceR1 on
CD4
+ T cells in human AAA lesions (Fig 8B).
IgE may also induce SMC apoptosis (Wang et al, 2011) in AAA
lesions. While regions of human AAA specimens rich in a-actin-
positive SMCs lacked detectable IgE signal (Fig 8C), many of the
sparse SMCs in other regions bore IgE, observation consistent with
a role for IgE in SMC depletion by apoptosis in human AAAs
(Fig 8D). Therefore, FceR1-positive SMCs in AAA lesions may be
particularly susceptible to apoptosis (Fig 8E). Some ECs in human
AAA lesions also display immunoreactive FceR1 and IgE (Fig 8F),
suggesting that IgE signaling might also contribute to EC death
(Wang et al, 2011) and intimal erosion, a possibility that merits
further investigation.
Discussion
This study establishes a role for IgE in experimental AAAs. Using
Ang-II infusion-induced experimental AAAs in Apoe
/ mice,
FceR1-deficient mice, adoptive transfer of leukocyte populations,
and anti-IgE mAb administration, we demonstrated that IgE actions
on CD4
+ T cells, MCs, and macrophages, and possibly other inflam-
matory and vascular cells contribute to AAA pathogenesis. This
study implicates release of pro-inflammatory cytokines after IgE
activation of leukocytes a major mechanism for affecting AAAs
among other possible pathways.
The present observations show a direct role of IgE in T cells. T-
cell functions in AAAs have been controversial, although, it is diffi-
cult to compare results obtained from different mouse models of
AAA and in different experimental settings. In peri-aortic CaCl2
injury-induced experimental AAAs, absence of CD4
+ T cells or Th1
cytokine IFN-c suppressed AAA formation. Intraperitoneal adminis-
tration of IFN-c partially reversed AAA formations in CD4
+ T-cell-
deficient mice (Xiong et al, 2004). In contrast, MHC mismatched
aortic transplantation-induced AAAs rely on Th2 cell functions.
Allografts from IFN-c receptor-deficient mice developed severe
AAA, which can be blocked by anti-IL4 antibody or compound defi-
ciency of IFN-c receptor and IL4 (Shimizu et al, 2004). Therefore,
both Th1 and Th2 cells may contribute to AAA formation differ-
ently, depending on the experimental model. In Ang-II infusion-
induced AAAs, however, complete elimination of all mature T cells
and B cells in Rag-1–deficient mice did not affect AAA incidence or
maximal aortic diameters in male or female mice, compared with
those with sufficient lymphocytes (Uchida et al,2 0 1 0 ) .T h i ss t u d yb y
Uchida et al may not definitively answer whether T cells or B cells
participate in AAAs, but among T cells or B cells, some may promote
AAA growth and some may inhibit AAA growth. For example,
innate-like B1 cells protect mice from diet-induced atherosclerosis
(Sun et al, 2010) and may also protect mice from AAA formation,
although currently no direct test exists for each T-cell or B-cell
subtype in experimental AAAs. The current study demonstrated
FceR1 expression on CD4
+ and CD8
+ T cells and a direct role of IgE
on T-cell activation. CD4
+ T cells expressed much more FceR1 mRNA
and proteins than did CD8
+ T cells (Fig 1A, B and D), leading to
differences in IL6 and IFN-c expression in response to IgE stimulation
(Fig 1E and F). Our data indicate a role for IL6 from CD4
+ Tc e l l si n
AAAs. Plasma IL6 levels in Apoe
/ mice, Apoe
/Fcer1a
/ mice,
and those that received CD4
+ and CD8
+ Tc e l l sf r o mApoe
/ mice
and Apoe
/Fcer1a
/ mice (Fig 7B and C), changed concordantly
with AAA lesion sizes (Fig 3C and Supplementary Fig S9C). In vitro
experiments showed that IgE suppresses CD4
+ T-cell IL10 expression
(Fig 1E and F), but we did not document significant change in plasma
IL10 levels between Apoe
/ and Apoe
/Fcer1a
/ mice, or those
that received different types of CD4
+ or CD8
+ Tc e l l s( S u p p l e m e n t a r y
Fig S12A–C). Nonetheless, local level of IL10 in AAA lesions influ-
enced by IgE could occur. The observation of inverse production of
IL6 and IL10 in human AAA lesion explant cultures, but not in
plasma from AAA patients (Vucevic et al, 2012), supports this
hypothesis.
IgE activation of MCs leads to MC degranulation and release of
inflammatory mediators (Gilfillan & Tkaczyk, 2006; Theoharides
et al, 2007), including cytokines, chemokines, and proteases. We
have previously demonstrated important roles of MCs and MC-
derived IL6, IFN-c, MCP-1, chymases and tryptases in three indepen-
dent experimental AAA preservations. By releasing these mediators,
MCs promote angiogenesis, monocyte migration, and vascular SMC
apoptosis (Sun et al, 2007b, 2009; Zhang et al, 2011, 2012). IgE activa-
tion of MCs may enhance the production of these MC mediators and
consequent AAA pathogenesis. Apoe
/Fcer1a
/ mice receiving MCs
from Apoe
/ mice but not those from Apoe
/Fcer1a
/ mice have
increased AAA lesion apoptosis and microvascularization (Fig 4C and
D), consistent with a regulatory role of IgE on MCs. As an indirect
mechanism, MCs release IL6 and IFN-c after activation to induce
vascular SMC and EC expression of cysteinyl cathepsins (Sun et al,
2007b), which also participate in arterial wall remodeling and AAA
pathogenesis (Sun et al, 2011, 2012; Qin et al, 2012). Indeed, adoptive
transfer of cultured MCs from Apoe
/ mice into Apoe
/Fcer1a
/
mice significantly enlarged AAA lesion sizes (Fig 4B) and increased
plasma IL6 levels (Fig 7D). The same adoptive transfer of MCs may
also change MC-specific proteases, although we are currently unable
to quantify mouse plasma chymase and tryptase due to a lack of suit-
able ELISA kits and to the complexity of different mouse chymase
(mouse mast cell protease [mMCP]-1, -2, -4, -5, and -9) and tryptase
(mMCP-6, -7, and -11) isoforms.
IgE activation of macrophages leads to macrophage apoptosis and
release of IL6, MCP-1, and possibly other pro-inflammatory
mediators (Wang et al, 2011). To our surprise, adoptive transfer of
macrophages from Apoe
/ mice did not significantly increase
plasma IL6 levels in Apoe
/Fcer1a
/ mice (Fig 7E). Consistently,
outer aortic diameters did not increase significantly in Apoe
/
Fcer1a
/ mice that received macrophages from Apoe
/ mice
(Fig 5B). These observations reaffirm that IgE regulation of plasma
IL6 correlated with AAA growth and also implicate IgE actions on
macrophages, including IL6 production, in experimental AAA forma-
tion, but for lesser extent than IgE actions on CD4
+ T cells or MCs.
IgE stimulation of vascular SMCs and ECs may also affect AAA
pathogenesis. We detected negligible IgE in SMC-rich regions in
human AAAs (Fig 8C). In contrast, IgE colocalized with SMC
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963paucicellular portions of human AAA lesions (Fig 8D), suggesting a
contribution of IgE to SMC apoptosis (Wang et al, 2011). In human
AAA lesions, IgE also colocalized with ECs (Fig 8F). Our prior in
vitro experiments from cultured human SMCs and ECs suggested
that IgE promotes EC apoptosis and cytokine production (Wang
et al, 2011). IgE-induced apoptosis of vascular cells may contribute
to SMC depletion in human AAA lesions (Fig 8D), and intimal
erosion.
In the inflammatory cell reconstitution tests in experimental
AAAs, we used CD4
+ Tc e l l s ,C D 8
+ T cells, MCs, and macrophages
Figure 8. IgE and FceR1 expression in human AAAs lesions.
A Immunostaining of human AAA lesion consecutive frozen sections to detect IgE and FceR1 expression in CD68-positive macrophages and TUNEL reactivity. Mouse
IgG and rabbit IgG were used as immunostaining negative controls for mouse anti-IgE and rabbit anti-FceR1 antibodies.
B Immunofluorescent double staining of CD4 and IgE or FceR1 to detect IgE and FceR1 expression in CD4
+ T cells.
C, D IgE and a-actin immunofluorescent double staining in smooth muscle cells (SMC)-rich and SMC-sparse areas.
EF c eR1 and a-actin immunofluorescent double staining to detect FceR1-positive SMCs.
FC D 31 and IgE or FceR1 immunofluorescent double staining of human AAA lesions.
Data information: Scale: 200 lm; insert scale: 60 lm. Arrows indicate IgE-positive or FceR1-positive CD4
+ T cells, SMCs or endothelial cells (ECs).
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964from both Apoe
/ and Apoe
/Fcer1a
/ mice. We assumed that
the only difference between the cells from Apoe
/ mice and those
from Apoe
/Fcer1a
/ mice was the expression of FceR1. IgE only
activates cells from Apoe
/ mice, not those from Apoe
/Fcer1a
/
mice (Wang et al, 2011), but absence of FceR1 may affect the expres-
sion of any other gene product, which may confound our data inter-
pretation from all adoptive transfer experiments (Figs 3, 4, 5 and
Supplementary Fig S9). We did not test this possibility in this study.
Instead, we treated Apoe
/ mice with anti-IgE antibody while these
mice received Ang-II infusion. This antibody should interrupt IgE
actions on all cells that express FceR1. Two doses of anti-IgE anti-
body to Ang-II-infused Apoe
/ mice effectively ablated plasma IgE
and inhibited AAA growth and associated lesion inflammation,
apoptosis, microvascularization, and cell proliferation to the same
extents as in Ang-II-infused Apoe
/Fcer1a
/ mice. These observa-
tions seem confirmative of IgE functions in AAA from Apoe
/
Fcer1a
/ mice, but have clinical significance. In a similar experi-
ment presented in our earlier study, we used MC-deficient mice to
prove a role of MCs in AAAs. In addition, we used over-the-counter
MC stabilizers and established an effective prevention of AAA
growth in aortic elastase perfusion-induced AAAs (Sun et al,
2007b). Anti-IgE antibodies such as omalizumab (also known as
rhuMab-E25 or Xolair
TM) and Talizumab (also known as TNX-901)
are currently approved by the U.S. Food and Drug Administration
(FDA) for clinical use in patients with allergic asthma, food aller-
gies, or other allergic conditions (Milgrom et al, 1999; Leung et al,
2003; Busse et al, 2011). Effective prevention of experimental AAAs
by anti-IgE antibody from this study suggests a potential clinical
application of omalizumab and Talizumab among AAA patients.
Materials and Methods
Mouse AAA production and lesion characterization
We crossbred Fcer1a
/ mice (C57BL/6, N9, provided by Marie-
Helene Jouvin and Jean-Pierre Kinet, Harvard Medical School) with
Apoe
/ mice (C57BL/6, N11, The Jackson Laboratory, Bar Harbor,
ME) to generate Apoe
/Fcer1a
/ mice and Apoe
/ control mice.
All mice used in this study were littermates in a syngeneic C57BL/6
background. To induce AAAs in Apoe
/Fcer1a
/ mice (n = 15)
and Apoe
/ control mice (n = 30), anesthetized (200 mg/kg
ketamine, 10 mg/kg xylazine, intraperitoneal) 2-month-old male
mice were infused with 1000 ng/kg/min Ang-II (Sigma-Aldrich, St.
Louis, MO) subcutaneously delivered by Alzet model 2004 osmotic
minipumps (DURECT Corp., Cupertino, CA) for 28 days while mice
consumed a high-fat diet (C12108; Research Diets, Inc., New Bruns-
wick, NJ). Post-operative analgesia (buprenophine, 0.05 mg/kg/
12 h, intraperitoneal) was administered every 12 h for 48 h. Mouse
body weights were recorded before and after Ang-II infusion. Mouse
diastolic and systolic blood pressures and heart rates were deter-
mined using the CODA non-invasive blood pressure system (Kent
Scientific Co., Torrington, CT). Mice were sacrificed with carbon
dioxide narcosis, followed by cardiac puncture blood collection.
Plasma IgE, IL6, IFN-c, IL10, and IgE levels were determined by
ELISA according to the manufacturer’s protocol (BD Biosciences,
San Jose, CA). Plasma total cholesterol, triglyceride, and
high-density lipoprotein (HDL) levels were determined using
reagents from Pointe Scientific (Canton, MI). Experimental aneu-
rysms were quantified using the methods of Daugherty et al as used
in our earlier studies (Daugherty et al, 2000; Schulte et al, 2010;
Zhang et al, 2012). The suprarenal maximal aortic diameter of each
aneurysm was measured after the peri-adventitial tissue was care-
fully dissected from the aortic wall. AAA incidence was defined by
increase of suprarenal maximal aortic diameter greater than 50% of
the mean value from same-age mice that received saline alone
(0.97  0.02 mm, n = 10), according to previously reported meth-
ods (Wang et al, 2006). The percentage of AAA incidence and
post-Ang-II infusion mortality rate per group were determined.
Determination of statistical significances between the groups used
the two-tailed Fisher’s exact test. All animal procedures conformed
with the Guide for the Care and Use of Laboratory Animals
published by the U.S. National Institutes of Health and were
approved by the Harvard Medical School Standing Committee on
Animals (protocol # 03759).
Mouse aortic tissue immunohistochemical analysis
Aorta segments for immunohistochemistry were cut at the maximal
suprarenal outer aortic diameter and embedded vertically with
optimal cutting temperature (OCT) compound, and at least 10–15
serial frozen sections covering the maximal dilated aorta were
prepared for immunohistochemical analysis as described previously
(Schulte et al, 2010; Zhang et al, 2012). For those with similarly
enlarged AAA diameter throughout the thoracic-abdominal aortas,
we selected the segment at approximately the same distance from
the renal artery as those of others with maximal AAA expansions.
In cases with AAA lesions at multiple locations, we selected the larg-
est lesion as close as possible to the same distance from the renal
artery as those of others with maximal AAA expansions. Slides of
each sample from identical levels were used for staining with each
antibody. Serial cryostat cross-sections (6 lm) were used for immu-
nostaining for macrophages (Mac-2, BD Biosciences, 1:1,000), T
cells (CD4, 1:90; BD Biosciences; and CD8, 1:300; Abcam,
Cambridge, MA), dendritic cells (CD11c, 1:40, BD Biosciences),
MHC-II (1:250; BD Biosciences), MCP-1 (1:50, BD Biosciences), elas-
tin (Verhoeff–van Gieson, Sigma-Aldrich), collagen (0.1% Sirius
Red F3BA; Polysciences Inc., Warrington, PA), a-actin (SMC, 1:750;
Sigma-Aldrich), Ki67 (cell proliferation marker, 1:500; Vector Labo-
ratories, Inc., Burlingame, CA), and CD31 (angiogenesis marker,
1:1,500; BD Biosciences). Lesion apoptotic cells were determined
with the in situ apoptosis detection kit, according to the manufac-
turer’s instructions (Millipore, Billerica, MA). Elastin degradation
and media SMC accumulation were graded according to the grading
keys described previously (Sun et al, 2007b). T cells, Ki67-positive
cells, apoptotic-positive cells, dendritic cells, and CD31-positive
microvessels were counted blindly. Unlike aortic cross sections from
fixed tissues that allowed counting of most individual immuno-
positive signals (Rateri et al, 2011), we prepared aortic cross
sections from unfixed abdominal aortas optimized for immunohisto-
chemical study, but not for reliable enumeration of all individual
immuno-positive cells. We therefore measured macrophage-
positive, MHC-II-positive, MCP-1-positive, and collagen-positive
areas using computer-assisted image analysis software (Image-Pro
Plus; Media Cybernetics, Bethesda, MD). Ang-II-induced AAAs often
show regions of disrupted media (Rateri et al, 2011), we calculated
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965AAA lesion areas from regions with both intact and fragmented
media (Schulte et al, 2010; Zhang et al, 2012).
BMMC, macrophage, T cell culture and adoptive transfer
To prepare BMMCs, bone-marrow cells from Apoe
/ and Apoe
/
Fcer1a
/ mice were cultured for 5–6 weeks in the presence of
mouse recombinant IL3 (PeproTech, Inc., Rocky Hill, NJ) and stem
cell factor (PeproTech), as reported previously (Sun et al, 2007a,b).
BMMC purity (nearly 100%) was confirmed with FACS analysis
using FITC-conjugated CD117 mAb (eBioscience, Inc., San Diego,
CA) (Sun et al, 2007a). Mouse thioglycolate-stimulated (3%, Sigma-
Aldrich) peritoneal macrophages were harvested from Apoe
/ and
Apoe
/Fcer1a
/ mice, cultured in plasma-free medium for 2 h,
suspension cells removed, adhesive macrophages harvested, and
macrophage purity examined using FACS with anti-CD11b-FITC and
anti-F4/80-APC mAbs (Caltag Laboratories, Burlingame, CA).
Peripheral CD4
+ and CD8
+ T cells from splenocytes of 8-week-old
Apoe
/ and Apoe
/Fcer1a
/ mice were first purified using a
Nylon column according to the manufacturer’s instructions (Poly-
sciences, Inc., Warrington, PA), followed by antibody/complement-
mediated depletion of B cells and CD8
+ T cells (purified I-A
b and
CD8a antibodies, BD Pharmingen) or B cells and CD4
+ T cells (puri-
fied I-A
b and CD4 antibodies, BD Pharmingen). Purified CD4
+ and
CD8
+ T cells were further purified by MACS-sorting using mouse T-
cell isolation kits according to the manufacturer’s instructions (Milt-
enyi Biotec Inc., Auburn, CA). Cell purity was confirmed by FACS
analysis using anti-CD3-APC, anti-CD4-PE, and anti-CD8-Alex700
mAbs (all from eBioscience, Inc.).
To reconstitute cells in vivo, 8-week-old male Apoe
/Fcer1a
/
mice were given in vitro prepared BMMCs (n = 18 for Apoe
/ cells
and n = 12 for Apoe
/Fcer1a
/ cells), peritoneal macrophages
(n = 14 for Apoe
/ cells and n = 10 for Apoe
/Fcer1a
/ cells),
CD4
+ (n = 20 for Apoe
/ cells and n = 15 for Apoe
/Fcer1a
/
cells), and CD8
+ (n = 25 for Apoe
/ cells and n = 10 for Apoe
/
Fcer1a
/ cells) T cells by tail vein injection (1 × 10
7 cells per
mouse). Unlike other methods of bone-marrow-cell transplantation,
irradiating the Apoe
/Fcer1a
/ recipient mice before receiving
donor cell intravenous transfer is not necessary, and donor cells
migrate to most organs and injured aortas. Recipient mice were
introduced to the Ang-II infusion-induced experimental AAAs 1 day
after tail vein injection. Donor cells in AAA lesions were confirmed
with immunostaining aortic sections with hamster anti-mouse
FceR1a mAb (1:100, eBioscience, Inc.) at harvesting. To minimize
inter-experimental variations, we used the Ang-II and minipump
from the same lot number and had the same investigator perform
implantation. We also planned the procedures on various experi-
mental groups including Apoe
/ and Apoe
/Fcer1a
/ control
mice so that some mice in each group were done each day, rather
than having only one condition processed per day.
Anti-IgE antibody treatment
Two-month-old male Apoe
/ mice received tail-vein injection of
rat anti-mouse IgE mAb (n = 11) in a dose previously validated in
mice (Coyle et al, 1996; Haile et al, 1999) (330 lg in 200 ll of saline
per 25 g body weight, BD Pharmingen) 1 day before the surgery.
Matched rat IgG1 isotype (n = 10, BD Pharmingen) was used as
negative control. Mice received a second dose of the same antibody
or IgG1 isotype 14 days after surgery. Mice were harvested 28 days
after initial Ang-II infusion.
T-cell real-time polymerase chain reaction (RT-PCR), FACS,
immunoblot analysis CD4
+ and CD8
+ T cells (2.5 × 10
6/ml) were
cultured in a complete medium (RPMI 1640 medium and 10% fetal
bovine serum) in anti-CD3 (1 lg/ml) mAb (BD Pharmingen) pre-
coated culture dishes. After treatment with different stimuli, includ-
ing INF-c (20 ng/ml), TNF-a (10 ng/ml), IL6 (20 ng/ml), IgE
(50 lg/ml), and Ang-II (100 nM), total cellular RNA was extracted
using Qiagen RNA isolation kit. Equal amounts of RNA were reverse
transcribed, and quantitative PCR was performed in a single-color
RT-PCR detection system (Stratagene, La Jolla, CA). The mRNA
levels of FceR1-a,F c eR1-b, and FceR1-c chains were normalized to
those of b-actin.
For flow cytometry, cells were stained with the proper combina-
tion of antibodies and analyzed on a flow cytometer FC500 (Beck-
man Coulter, Brea, CA). The following antibodies were used for T-
cell flow cytometry: anti-CD3-APC, anti-CD4-PE, anti-FceR1a-biotin,
anti-CD8-Alex700 mAbs (all from eBioscience, Inc.). For surface
staining, cells were incubated with antibodies for 20 min at 4°C. For
intracellar staining, cells were fixed and permeabilized according to
the manufacturer’s instructions (eBioscience, Inc.) before adding the
anti-FceR1a-biotin antibody. Isotype controls were used to correct
compensation and to confirm antibody specificity. All samples were
analyzed using flow cytometry on a FACSCalibur (BD Biosciences).
For immunoblot analysis, an equal amount of protein from each
cell type preparation was separated by SDS–PAGE, blotted, and
detected with mAbs against mouse FceR1a (1:1,000; eBioscience,
Inc.) and b-actin (used for protein loading control, 1:1,000; Santa
Cruz Biotechnology Inc., Santa Cruz, CA).
T-cell survival, proliferation, and cytokine production
To test whether IgE affects T-cell survival and proliferation, we
seeded different numbers of CD4
+ or CD8
+ T cells (2.5 × 10
5 to
1 × 10
6 per well) on a 96-well flat-bottomed tissue culture plate
containing both anti-CD3 (1 lg/ml) and anti-CD28 (1 lg/ml) anti-
bodies. Cells were treated with murine IgE (50 lg/ml; Sigma-
Aldrich) for 3 days. MTT assay was then used to detect cell survival,
according to the manufacturer’s instructions (Millipore). Medium
absorbance was read at 570 nm. ELISA (BD Biosciences) was then
used to determine IL12 levels from T-cell culture media.
To detect cytokine production in CD4
+ and CD8
+ T cells, T cells
(2.5 × 10
6/ml) were cultured in a complete medium (RPMI 1640
medium and 10% fetal bovine serum) in anti-CD3 mAb (1 lg/ml,
BD Pharmingen) pre-coated plates in the presence or absence of
different doses of IgE (0–100 lg/ml; Sigma-Aldrich) for 2 days. Cells
were collected for total RNA preparation using the Qiagen RNA
isolation kit for RT-PCR (Bio-Rad, Hercules, CA) to determine
mRNA levels of IL6, IFN-c, and IL10. Cell culture media were
collected to measure secreted cytokines by ELISA, according to the
manufacturer’s instructions (BD Biosciences).
Patient population and IgE ELISA
In an ongoing randomized population-based screening trial for
AAAs, PAD, and hypertension in more than 50,000 men 65–
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96674 years of age in the mid-region of Denmark (Grøndal et al, 2010),
baseline plasma samples were taken consecutively at diagnosis of
476 AAA patients and 200 age-matched controls without AAA or
PAD. AAA was defined as having maximal aortic diameter greater
than 30 mm, and PAD was defined as an ankle-brachial index (ABI)
lower than 0.90 or >1.4. Ankle systolic blood pressure was
measured as previously validated and reported (Joensen et al,
2008), and maximal anterior–posterior diameter of the infrarenal
aorta was measured in the peak of the systole from inner edge to
inner edge of the aorta. Patients with AAAs less than 50 mm were
offered annual control scans by the screening team; patients with
AAAs measuring 50 mm or larger were referred for a computed
tomography (CT) scan and vascular surgical evaluation. The inter-
observer variation of aortic diameter measurements was 1.52 mm
(Grøndal et al, 2012). Growth rates of small AAAs in patients kept
under surveillance were calculated by individual linear regression
analysis, using all observations. Blood samples were centrifuged at
3,000 g for 12 min, aliquoted, and stored at 80°C until analysis
was performed. All subjects gave informed consent before partici-
pating, and the Local Ethics Committee of the Viborg Hospital,
Denmark, approved the study, which was performed in accordance
with the Helsinki Declaration. The Partners Human Research
Committee (Boston, MA) also approved the use of non-coded
human samples. Plasma IgE levels were determined using the
Human IgE Ready-SET-Go! according to the manufacturer’s instruc-
tions (eBioscience, Inc.).
Human AAA lesion immunohistology
Immunohistochemistry with mouse anti-human IgE (1:70, Southern
Biotech, Birmingham, AL) and rabbit anti-human FceR1 (1:300;
Santa Cruz Biotechnology) and their colocalization with apoptosis
(TUNEL, Apoptosis Tag kit; Millipore) was performed on acetone
fixed frozen sections from human AAA (n = 11) and control normal
aortas (n = 5) by avidin/biotin method. Specimens obtained by
protocols approved by the Human Investigation Review Committee
at the Brigham and Women’s Hospital were immediately immersed
in saline, embedded in OCT, and stored at 80°C freezer. To local-
ize IgE and FceR1 to vascular SMCs, ECs, and CD4
+ T cells, we
performed double immunofluorescent staining (n = 11) with mouse
anti-IgE (1:10) or rabbit anti-FceR1 (1:80) antibodies incubated over-
night, followed by anti-mouse or anti-rabbit Alexa-555 (Invitrogen,
Grand Island, NY). Sections were washed, blocked with 4% of
appropriate normal serum, and incubated with mouse anti-a-actin
(1:40, HHF35; Enzo-Diagnostics, Syosset, NY), CD31 (1:40, Dako,
Carpinteria, CA), and CD4 (1:20, Dako), followed by anti-mouse
Alexa-488 (Invitrogen).
Statistical analysis
One sample Kolmogorov–Smirnov test and probability plot (not
shown) were used to determine whether human plasma IgE levels
were normally distributed, and compared between controls and
cases with Student’s t-test and the Mann–Whitney U test. ROC curve
analyses were performed non-parametrically to test the predictive
value of the test, concerning the prediction of AAA cases. For analy-
ses of the ROC curves, the null hypothesis was that the test
performed similarly to the diagonal line—i.e. the area under the
curve was 0.5. If the lowest 95% confidence limit for the area under
the curve was above 0.5, a significant predictive test was present.
The optimal cut-off points were determined, and the respective sensi-
tivity and specificity were calculated. The associations of plasma IgE
were correlated to maximal aortic diameter, lowest ABI, and AAA
growth rate by Spearman’s correlation test. Because of relatively
small sample sizes and often skewed data distribution, we selected
the non-parametric Mann–Whitney U test for paired data sets and
one-way ANOVA with post-hoc Bonferroni test was used for compar-
ison among three or more groups to examine statistical significance
for all data from cultured cells and experimental AAAs. Fisher’s exact
test was used to compare the differences in AAA incidence and post-
Ang-II mortality. P < 0.05 was considered statistically significant.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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The paper explained
Problem
We previously showed that immunoglobulin E (IgE) activates cultured
MCs and macrophages, both are important pro-inflammatory cells in
human and experimental AAAs. However, it remains unknown
whether IgE activation of these cells or other inflammatory cells
contributes to AAA pathogenesis, and whether it is possible that inter-
ruption of this IgE activity ameliorates AAA development.
Results
This study demonstrates that not only MCs and macrophages, but
also CD4
+ and CD8
+ T cells express IgE receptor FceR1. IgE induces
CD4
+ T-cell production of pro-inflammatory cytokines IL6 and IFN-c,
but reduces their production of anti-inflammatory cytokine IL10.
Genetic depletion of this IgE receptor protects mice from chronic
angiotensin II infusion-induced AAAs. We are also able to reverse
reduced AAAs and plasma IL6 levels in FceR1-deficient mice by repopu-
lating CD4
+ T cells, MCs, and macrophages from FceR1-sufficient mice
but not those from FceR1-deficient mice. Relevant to clinical implica-
tion, we demonstrate that biweekly intravenous administration of an
anti-IgE monoclonal antibody reduces plasma IgE by more than 70%
and yields similar suppression of AAAs to those in FceR1-deficient mice.
In humans, we also discover that AAA patients have higher plasma IgE
levels than those without AAAs.
Impact
This study establishes an important role of IgE in AAA formation by
activating inflammatory cells, including CD4
+ T cells, MCs, macro-
phages, and possibly other untested cell types. Reduced AAAs in mice
that are genetic deficient for IgE receptor FceR1 or that receive treat-
ment with an anti-IgE monoclonal antibody suggest a future therapeu-
tic potential of this aortic disease using anti-IgE antibodies, such as
omalizumab and Talizumab that are currently used widely among
patients with asthma or other allergic diseases.
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